Clinical Trial Update: Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose immunotherapy for metastatic and locally advanced colorectal and gastric MSI/dMMR cancers; currently enrolling by inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Colorectal Cancer, Gastric Cancer | Phase 2 | Status: ENROLLING_BY_INVITATION